Crown Asia Investment

Overview

Crown Asia Investment is a private equity firm based in Shanghai, China, focusing on industrial and equity investments across various sectors. The firm engages in industrial investment, equity investment, and investment management, aiming to create value through strategic partnerships and active management. The firm's investment strategy encompasses a broad range of industries, including healthcare, technology, consumer products, financial services, media, education, energy, real estate, telecommunications, transportation, retail, manufacturing, agriculture, chemicals, and pharmaceuticals. This diversified approach allows Crown Asia Investment to leverage opportunities across different sectors and regions. Crown Asia Investment's portfolio includes investments in companies such as Crown Bioscience, a global contract research organization providing discovery, preclinical, and translational platforms and services to advance oncology and immuno-oncology drug discovery and development. The firm also invests in various sectors, including healthcare, technology, consumer products, financial services, media, education, energy, real estate, telecommunications, transportation, retail, manufacturing, agriculture, chemicals, and pharmaceuticals, reflecting its diversified investment approach. The firm's investment philosophy centers on creating value through strategic partnerships and active management, aiming to enhance the growth and competitiveness of its portfolio companies. By leveraging its network and industry expertise, Crown Asia Investment seeks to unlock long-term value for stakeholders across its diverse investments.

Investment Focus

• Strong management team
• Scalable business model
• Competitive market position
• Clear growth strategy
• Potential for operational improvement
• Alignment with firm's investment criteria

Portfolio Companies